...
首页> 外文期刊>Asian Journal of Pharmaceutical and Clinical Research >SCREENING AND MOLECULAR DOCKING STUDIES OF NEW NATURAL AGONISTS AGAINST PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA TARGETED TO TREAT OBESITY
【24h】

SCREENING AND MOLECULAR DOCKING STUDIES OF NEW NATURAL AGONISTS AGAINST PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR-ALPHA TARGETED TO TREAT OBESITY

机译:靶向过肥胖的过氧化物酶体增殖物激活的受体-α的新型天然激动剂的筛选和分子对接研究

获取原文
           

摘要

Objective: Obesity was considered as a serious health concern apart from the age group in today’s population globally. The percentage of obese people in the world’s population is increasing at a faster rate, and health issues arising due to obesity are gradually increasing. Our present insilico study was aimed to screen out natural molecules against the peroxisome proliferator-activated receptor (PPAR), especially alpha aids in triggering the obesity. Methods: Several targets for treating obesity were identified, and one among such promising target was PPAR. Using the insilico applications such as natural database was screened and the molecules were further evaluated based on their docking score parameter with the receptor. Results: The docking methodology suggested that two molecules zinc02091671 and zinc02137525 were found to reproduce the similar type of interactions such as that of the known inhibitor and crystal ligand. Conclusion: The reported two molecules were found to be promising agonists based on the computational studies and can be advanced the in vitro based evaluation.
机译:目标:在当今全球人口中,肥胖症被视为严重的健康问题,而不是年龄组。肥胖人口在世界人口中的比例正在以更快的速度增长,并且由于肥胖引起的健康问题也在逐步增加。我们目前的分子生物学研究旨在筛选出针对过氧化物酶体增殖物激活受体(PPAR)的天然分子,尤其是α辅助引发肥胖症。方法:确定了治疗肥胖的几个目标,其中一个有希望的目标是PPAR。使用诸如天然数据库之类的电子应用程序进行筛选,并根据分子与受体的对接得分参数进一步评估分子。结果:对接方法表明,发现两个分子zinc02091671和zinc02137525可以复制相似类型的相互作用,例如已知抑制剂和晶体配体的相互作用。结论:根据计算研究发现,报道的两种分子是有希望的激动剂,可用于体外评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号